Indian drug manufacturers are utilizing flagship products or “mother brands” to introduce new combinations and establish leadership in therapy areas, as per research by Pharmarack. For example, USV’s anti-diabetes drug Glycomet has bolstered the company’s reputation in diabetic therapy and facilitated partnerships with multinational drugmakers for innovative therapies.
